These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37535772)

  • 1. A Network Meta-Analysis of Randomized Clinical Trials to Assess the Efficacy and Safety of Antiviral Agents for Immunocompetent Patients with Herpes Zoster-Associated Pain.
    Liu Y; Xiao S; Li J; Long X; Zhang Y; Li X
    Pain Physician; 2023 Jul; 26(4):337-346. PubMed ID: 37535772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral treatment for preventing postherpetic neuralgia.
    Chen N; Li Q; Yang J; Zhou M; Zhou D; He L
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD006866. PubMed ID: 24500927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment for preventing postherpetic neuralgia.
    Li Q; Chen N; Yang J; Zhou M; Zhou D; Zhang Q; He L
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006866. PubMed ID: 19370655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
    Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster.
    Ono F; Yasumoto S; Furumura M; Hamada T; Ishii N; Gyotoku T; Higuchi M; Inokuchi K; Jyo K; Koga H; Komai A; Maruta K; Mashiko T; Mihara T; Miyahara H; Miyasato M; Muto K; Nagase K; Nagata M; Sakihama H; Tanahashi T; Ueda A; Yamakawa K; Ohata C; Dainichi T; Tsuruta D; Hashimoto T
    J Dermatol; 2012 Nov; 39(11):902-8. PubMed ID: 22670895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
    Tyring SK; Beutner KR; Tucker BA; Anderson WC; Crooks RJ
    Arch Fam Med; 2000; 9(9):863-9. PubMed ID: 11031393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valaciclovir: a review of its use in the management of herpes zoster.
    Ormrod D; Goa K
    Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials.
    McDonald EM; de Kock J; Ram FS
    Antivir Ther; 2012; 17(2):255-64. PubMed ID: 22300753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of different doses of antiviral agents in the treatment of herpes zoster: a meta-analysis].
    Deng YX; Hu J; Li HM
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(40):3192-3200. PubMed ID: 36319173
    [No Abstract]   [Full Text] [Related]  

  • 10. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?
    Alper BS; Lewis PR
    J Fam Pract; 2000 Mar; 49(3):255-64. PubMed ID: 10735485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of herpes zoster.
    Opstelten W; Eekhof J; Neven AK; Verheij T
    Can Fam Physician; 2008 Mar; 54(3):373-7. PubMed ID: 18337531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
    Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
    J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
    Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-day famciclovir treatment significantly reduces the incidence of postherpetic neuralgia in elderly patients with herpes zoster.
    Kong J; Wang H; Liu Y; Xiao M; Wang J; Liu Q
    J Clin Pharm Ther; 2022 Nov; 47(11):1805-1810. PubMed ID: 36116793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
    Schuster AK; Harder BC; Schlichtenbrede FC; Jarczok MN; Tesarz J
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011503. PubMed ID: 27841441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.
    Tyring SK; Lee P; Hill GT; Silverfield JC; Moore AY; Matkovits T; Sullivan-Bolyai J
    J Med Virol; 2017 Jul; 89(7):1255-1264. PubMed ID: 27943311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis.
    Jackson JL; Gibbons R; Meyer G; Inouye L
    Arch Intern Med; 1997 Apr; 157(8):909-12. PubMed ID: 9129551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for men and women with their first episode of genital herpes.
    Heslop R; Roberts H; Flower D; Jordan V
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010684. PubMed ID: 27575957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of famciclovir in the treatment of herpes zoster.
    Tyring SK
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):27-31. PubMed ID: 8840413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.